Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2003-4-11
pubmed:abstractText
To evaluate the effectiveness of oral amoxicillin/clavulanate (25 mg/kg every 12 h) for prevention of fever and/or infection in neutropenic children with cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0891-3668
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
359-65
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12690278-Adolescent, pubmed-meshheading:12690278-Amoxicillin-Potassium Clavulanate Combination, pubmed-meshheading:12690278-Antibiotic Prophylaxis, pubmed-meshheading:12690278-Child, pubmed-meshheading:12690278-Child, Preschool, pubmed-meshheading:12690278-Dose-Response Relationship, Drug, pubmed-meshheading:12690278-Double-Blind Method, pubmed-meshheading:12690278-Drug Administration Schedule, pubmed-meshheading:12690278-Female, pubmed-meshheading:12690278-Fever, pubmed-meshheading:12690278-Follow-Up Studies, pubmed-meshheading:12690278-Humans, pubmed-meshheading:12690278-Infant, pubmed-meshheading:12690278-Male, pubmed-meshheading:12690278-Neoplasms, pubmed-meshheading:12690278-Neutropenia, pubmed-meshheading:12690278-Patient Compliance, pubmed-meshheading:12690278-Prospective Studies, pubmed-meshheading:12690278-Risk Assessment, pubmed-meshheading:12690278-Treatment Outcome
pubmed:year
2003
pubmed:articleTitle
A multicenter, randomized, double blind placebo-controlled trial of amoxicillin/clavulanate for the prophylaxis of fever and infection in neutropenic children with cancer.
pubmed:affiliation
Infectious Disease Unit, National Institute for Cancer Research, Largo Rosanna Benzi 10, 16132 Genoa, Italy.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study